Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls
- 23 June 2022
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 61 (11) , 670-677
Abstract
Background: Mesenchymal chondrosarcoma (MCS) is a rare translocation‐associated sarcoma, driven by a canonical HEY1::NCOA2 fusion. The tumors typically have a biphasic phenotype of primitive small blue round cells intermixed with hyaline cartilage. The head and neck (HN) region is a common site for MCS, accounting for 12–45% of all cases reported.Aims: We assembled a relatively large cohort of 13 molecularly confirmed HN MCS for a detailed clinicopathologic analysis. The underlying fusion events were determined using fluorescence in situ hybridization and/or targeted RNA sequencing.Results: The median age of presentation was 19 years. Five MCSs (39%) had an intraosseous presentation (skull, maxilla, palate, and mandible), while the remaining eight cases occurred in the brain/meninges, orbit, and nasal cavity. Microscopically, HN MCSs were characterized by primitive round cells arranged in a distinctive nested architecture and a rich staghorn vasculature. A cartilaginous component of hyaline cartilage islands and/or single chondrocytes were present in 69% cases. A combined immunoprofile of CD99(+)/SATB2(+)/CD34(−)/STAT6(−) was typically noted. As this immunoprofile is non‐specific, the referral diagnoses in cases lacking a cartilaginous component included Ewing sarcoma family and osteosarcoma. Among the seven patients with follow‐up data, three developed distant metastasis and one died of disease.Conclusion: HN MCS may arise at intra‐ or extra‐osseous sites. The HN MCS appears to have a more prolonged survival compared other MCS sites. Testing for HEY1::NCOA2 fusion is recommended in HN tumors with nested round cell morphology and staghorn vasculature that lack a distinctive cartilaginous component.Keywords
Funding Information
- National Institutes of Health
This publication has 28 references indexed in Scilit:
- The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcomaVirchows Archiv, 2014
- Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimicsLaboratory Investigation, 2014
- Detection of HEY1‐NCOA2 fusion by fluorescence in‐situ hybridization in formalin‐fixed paraffin‐embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcomaPathology International, 2012
- Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal ChondrosarcomaPLOS ONE, 2012
- Mesenchymal Chondrosarcoma: Clinicopathologic Study of 20 CasesArchives of Pathology & Laboratory Medicine, 2012
- Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression dataGenes, Chromosomes and Cancer, 2011
- Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adultsCancer, 2008
- Mesenchymal chondrosarcoma of the head and neckOral Oncology, 2007
- Mesenchymal chondrosarcoma of the thyroid – a rare tumour at an unusual siteAPMIS, 2004
- Mesenchymal Chondrosarcoma of the Sinonasal Tract: A Clinicopathological Study of 13 Cases With a Review of the LiteratureThe Laryngoscope, 2003